Allmed Cost Of Revenue vs Total Revenue Analysis

002950 Stock

8.99 0.11 1.21%

Allmed Medical financial indicator trend analysis is way more than just evaluating Allmed Medical Products prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Allmed Medical Products is a good investment. Please check the relationship between Allmed Medical Cost Of Revenue and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allmed Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Allmed Medical Products Cost Of Revenue account and Total Revenue. At this time, the significance of the direction appears to have totally related.

The correlation between Allmed Medical's Cost Of Revenue and Total Revenue is 0.99. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Allmed Medical Products, assuming nothing else is changed. The correlation between historical values of Allmed Medical's Cost Of Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Allmed Medical Products are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Cost Of Revenue i.e., Allmed Medical's Cost Of Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Allmed Medical Products income statement and represents the costs associated with goods and services Allmed Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Revenue

Total revenue comprises all receipts Allmed Medical Products generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Allmed Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Allmed Medical Products current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allmed Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 84.1 M. The current year's Selling General Administrative is expected to grow to about 151.3 M

	2021	2022	2023	2024 (projected)
Gross Profit	881.5M	1.4B	768.6M	994.9M
Total Revenue	2.9B	4.2B	2.8B	2.9B

Gross Profit Total Revenue

Allmed Medical fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Liab	Other Liab	Net Tangible Assets	Net Debt	Other Assets	Long Term Debt	Common Stock Shares Outstanding	Other Stockholder Equity
Total Assets		0.93	0.98	0.99	0.72	0.63	0.97	-0.49	0.83	0.71	0.89	0.95	0.15	0.96	0.82	0.93	0.87	0.9	0.15	0.92	0.97	0.06	0.61	-0.52	0.84	-0.96
Total Current Liabilities	0.93		0.85	0.88	0.82	0.62	0.9	-0.37	0.73	0.78	0.76	0.84	0.03	0.98	0.84	0.86	0.7	0.82	0.16	0.83	0.81	0.16	0.56	-0.56	0.62	-0.93
Total Stockholder Equity	0.98	0.85		0.99	0.65	0.64	0.95	-0.55	0.81	0.67	0.86	0.93	0.15	0.9	0.76	0.92	0.87	0.86	0.14	0.93	0.99	-0.03	0.65	-0.53	0.9	-0.93
Retained Earnings	0.99	0.88	0.99		0.62	0.7	0.94	-0.46	0.8	0.63	0.87	0.93	0.19	0.93	0.83	0.95	0.88	0.89	0.23	0.91	0.99	0.06	0.64	-0.54	0.86	-0.94
Accounts Payable	0.72	0.82	0.65	0.62		0.18	0.77	-0.48	0.59	0.97	0.54	0.65	-0.2	0.77	0.39	0.55	0.47	0.54	-0.29	0.68	0.57	-0.16	0.46	-0.45	0.47	-0.7
Cash	0.63	0.62	0.64	0.7	0.18		0.44	0.01	0.29	0.23	0.44	0.53	0.29	0.59	0.8	0.83	0.47	0.59	0.69	0.45	0.67	0.14	0.43	-0.66	0.42	-0.6
Non Current Assets Total	0.97	0.9	0.95	0.94	0.77	0.44		-0.56	0.83	0.76	0.86	0.9	-0.01	0.94	0.72	0.8	0.83	0.85	-0.04	0.97	0.92	0.04	0.67	-0.46	0.86	-0.95
Non Currrent Assets Other	-0.49	-0.37	-0.55	-0.46	-0.48	0.01	-0.56		-0.5	-0.56	-0.33	-0.46	0.27	-0.38	-0.1	-0.34	-0.43	-0.2	0.55	-0.56	-0.52	0.33	-0.39	0.19	-0.72	0.53
Net Receivables	0.83	0.73	0.81	0.8	0.59	0.29	0.83	-0.5		0.5	0.88	0.93	0.23	0.82	0.61	0.74	0.81	0.8	0.07	0.78	0.79	-0.04	0.31	-0.21	0.71	-0.79
Short Term Investments	0.71	0.78	0.67	0.63	0.97	0.23	0.76	-0.56	0.5		0.48	0.61	-0.2	0.73	0.36	0.56	0.47	0.48	-0.34	0.68	0.59	-0.19	0.51	-0.48	0.52	-0.68
Non Current Liabilities Total	0.89	0.76	0.86	0.87	0.54	0.44	0.86	-0.33	0.88	0.48		0.96	0.4	0.88	0.76	0.82	0.91	0.97	0.11	0.76	0.84	0.19	0.32	-0.19	0.76	-0.8
Inventory	0.95	0.84	0.93	0.93	0.65	0.53	0.9	-0.46	0.93	0.61	0.96		0.33	0.93	0.76	0.91	0.91	0.92	0.14	0.82	0.91	0.03	0.39	-0.35	0.79	-0.87
Other Current Assets	0.15	0.03	0.15	0.19	-0.2	0.29	-0.01	0.27	0.23	-0.2	0.4	0.33		0.15	0.31	0.36	0.51	0.34	0.4	-0.12	0.19	0.41	-0.53	0.43	0.0	0.09
Total Liab	0.96	0.98	0.9	0.93	0.77	0.59	0.94	-0.38	0.82	0.73	0.88	0.93	0.15		0.86	0.89	0.81	0.91	0.16	0.85	0.87	0.18	0.51	-0.47	0.7	-0.94
Short Long Term Debt	0.82	0.84	0.76	0.83	0.39	0.8	0.72	-0.1	0.61	0.36	0.76	0.76	0.31	0.86		0.86	0.73	0.86	0.5	0.67	0.76	0.48	0.4	-0.41	0.55	-0.81
Total Current Assets	0.93	0.86	0.92	0.95	0.55	0.83	0.8	-0.34	0.74	0.56	0.82	0.91	0.36	0.89	0.86		0.82	0.86	0.39	0.75	0.92	0.07	0.45	-0.54	0.72	-0.85
Short Term Debt	0.87	0.7	0.87	0.88	0.47	0.47	0.83	-0.43	0.81	0.47	0.91	0.91	0.51	0.81	0.73	0.82		0.83	0.13	0.77	0.88	0.28	0.3	-0.08	0.78	-0.73
Intangible Assets	0.9	0.82	0.86	0.89	0.54	0.59	0.85	-0.2	0.8	0.48	0.97	0.92	0.34	0.91	0.86	0.86	0.83		0.24	0.76	0.84	0.22	0.41	-0.36	0.72	-0.84
Other Current Liab	0.15	0.16	0.14	0.23	-0.29	0.69	-0.04	0.55	0.07	-0.34	0.11	0.14	0.4	0.16	0.5	0.39	0.13	0.24		0.04	0.21	0.25	0.06	-0.29	-0.12	-0.11
Other Liab	0.92	0.83	0.93	0.91	0.68	0.45	0.97	-0.56	0.78	0.68	0.76	0.82	-0.12	0.85	0.67	0.75	0.77	0.76	0.04		0.92	-0.01	0.79	-0.52	0.87	-0.93
Net Tangible Assets	0.97	0.81	0.99	0.99	0.57	0.67	0.92	-0.52	0.79	0.59	0.84	0.91	0.19	0.87	0.76	0.92	0.88	0.84	0.21	0.92		-0.01	0.65	-0.52	0.9	-0.91
Net Debt	0.06	0.16	-0.03	0.06	-0.16	0.14	0.04	0.33	-0.04	-0.19	0.19	0.03	0.41	0.18	0.48	0.07	0.28	0.22	0.25	-0.01	-0.01		-0.24	0.45	-0.13	-0.02
Other Assets	0.61	0.56	0.65	0.64	0.46	0.43	0.67	-0.39	0.31	0.51	0.32	0.39	-0.53	0.51	0.4	0.45	0.3	0.41	0.06	0.79	0.65	-0.24		-0.78	0.68	-0.72
Long Term Debt	-0.52	-0.56	-0.53	-0.54	-0.45	-0.66	-0.46	0.19	-0.21	-0.48	-0.19	-0.35	0.43	-0.47	-0.41	-0.54	-0.08	-0.36	-0.29	-0.52	-0.52	0.45	-0.78		-0.41	0.63
Common Stock Shares Outstanding	0.84	0.62	0.9	0.86	0.47	0.42	0.86	-0.72	0.71	0.52	0.76	0.79	0.0	0.7	0.55	0.72	0.78	0.72	-0.12	0.87	0.9	-0.13	0.68	-0.41		-0.84
Other Stockholder Equity	-0.96	-0.93	-0.93	-0.94	-0.7	-0.6	-0.95	0.53	-0.79	-0.68	-0.8	-0.87	0.09	-0.94	-0.81	-0.85	-0.73	-0.84	-0.11	-0.93	-0.91	-0.02	-0.72	0.63	-0.84

Click cells to compare fundamentals

Allmed Medical Account Relationship Matchups

Allmed Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.2B	4.9B	5.0B	5.7B	5.1B	4.3B
Total Current Liabilities	620.4M	1.5B	1.6B	2.1B	1.3B	1.3B
Total Stockholder Equity	2.1B	2.9B	2.8B	3.1B	3.2B	2.4B
Retained Earnings	840.8M	1.7B	1.6B	1.7B	1.7B	1.2B
Accounts Payable	107.6M	143.9M	253.9M	897.3M	326.1M	296.3M
Cash	242.5M	1.3B	678.5M	522.2M	397.0M	544.4M
Non Current Assets Total	1.5B	2.0B	2.8B	3.3B	3.3B	2.3B
Non Currrent Assets Other	16.2M	51.0M	40.1M	10.4M	692.8K	658.1K
Net Receivables	446.9M	238.5M	589.0M	483.2M	376.4M	380.3M
Short Term Investments	1.1M	35.6M	8.1M	264.6M	96.8M	64.5M
Non Current Liabilities Total	476.2M	467.7M	614.2M	549.6M	547.9M	504.5M
Inventory	708.6M	707.3M	846.6M	877.3M	707.2M	711.3M
Other Current Assets	264.1M	243.9M	119.6M	81.9M	56.2M	53.4M
Total Liab	1.1B	1.9B	2.3B	2.6B	1.9B	1.8B
Short Long Term Debt	362.2M	1.1B	1.1B	792.1M	749.6M	800.5M
Total Current Assets	1.7B	2.8B	2.2B	2.4B	1.8B	2.0B
Intangible Assets	161.2M	219.5M	234.7M	213.6M	202.7M	208.6M
Other Current Liab	41.7M	161.7M	144.0M	16.1M	7.8M	7.4M
Other Liab	245.8M	289.4M	367.7M	486.0M	558.9M	360.7M
Net Tangible Assets	1.1B	1.9B	2.7B	2.5B	2.9B	2.0B
Net Debt	765.2M	306.4M	508.7M	381.3M	498.9M	386.2M
Other Assets	94.1M	106.2M	137.6M	139.2M	160.1M	132.0M
Long Term Debt	186.7M	100M	127.6M	111.4M	146.3M	120.5M
Other Stockholder Equity	582.5K	5.1M	(40.2M)	(63.6M)	(57.3M)	(54.4M)
Deferred Long Term Liab	565.9K	1.1M	1.3M	1.1M	1.0M	1.0M
Net Invested Capital	2.6B	4.1B	3.9B	4.0B	4.1B	3.6B
Net Working Capital	1.0B	1.4B	604.5M	332.0M	454.1M	681.2M
Property Plant Equipment	1.2B	1.2B	1.3B	1.6B	1.8B	1.4B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Allmed Stock

Balance Sheet is a snapshot of the financial position of Allmed Medical Products at a specified time, usually calculated after every quarter, six months, or one year. Allmed Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Allmed Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Allmed currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Allmed Cost Of Revenue vs Total Revenue Analysis

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Total Revenue

Allmed Medical fundamental ratios Correlations

Allmed Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Allmed Medical fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Allmed Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Net Tangible Assets	+ 0.99	Retained Earnings
Total Stockholder Equity	+ 0.98	Total Assets
Total Liab	+ 0.98	Total Current Liabilities

Other Stockholder Equity	- 0.96	Total Assets
Other Stockholder Equity	- 0.95	Non Current Assets Total
Other Stockholder Equity	- 0.94	Total Liab
Other Stockholder Equity	- 0.94	Retained Earnings
Other Stockholder Equity	- 0.93	Other Liab
Other Stockholder Equity	- 0.93	Total Stockholder Equity